Literature DB >> 25598405

Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis. More doubts than clarity.

Alessandro Cucchetti1, Matteo Cescon1, Antonio Daniele Pinna1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25598405     DOI： 10.1002/hep.27702

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Clinical value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertension.

Authors:  Yan Zhang; Da-Feng Mao; Mei-Wu Zhang; Xiao-Xiang Fan
Journal:  World J Gastroenterol       Date:  2017-12-07       Impact factor: 5.742

2.  Nanoliposome C6-Ceramide in combination with anti-CTLA4 antibody improves anti-tumor immunity in hepatocellular cancer.

Authors:  Xiaoqiang Qi; Feng Wu; Sung Hoon Kim; Jussuf T Kaifi; Eric T Kimchi; Helena Snyder; Anuradha Illendula; Todd Fox; Mark Kester; Kevin F Staveley-O'Carroll; Guangfu Li
Journal:  FASEB J       Date:  2022-04       Impact factor: 5.834

Review 3.  HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma.

Authors:  Xiaolong Qi; Xin Zhang; Zhijia Li; Jialiang Hui; Yi Xiang; Jinjun Chen; Jianbo Zhao; Jing Li; Fu-Zhen Qi; Yong Xu
Journal:  Oncotarget       Date:  2016-09-20

Review 4.  Surgical Treatment of Hepatocellular Carcinoma.

Authors:  Daniel Zamora-Valdes; Timucin Taner; David M Nagorney
Journal:  Cancer Control       Date:  2017 Jul-Sep       Impact factor: 3.302
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.